Refine by
Catheterization Articles & Analysis: Older
23 news found
This breakthrough technology has huge market potential, as it could be used as an alternative to the invasive catheterization procedure currently used to obtain FFR. Coronary artery disease is the most common type of heart disease in the US. ...
Patients presenting to the hospital or outpatient clinic with clinical worsening HF underwent blood volume analysis measured with Daxor’s BVA-100 diagnostic blood test, right heart catheterization, provocative testing including blood pressure measurement, leg raises, breathing techniques, and patient symptoms and physical exam findings. ...
The EXPANDER-1 study confirms that the procedure is a safe and minimally invasive BPH treatment that can potentially avoid post-procedure catheterization and preserves sexual function. In addition, the XFLO Expander System was demonstrated to be effective at providing immediate symptom relief (2 weeks post-implant) with 40% reduction in IPSS (International Prostate Symptom Score) ...
Since 1980 he was a Director of the Clinical Research Program of the Catheterization Laboratory, Thorax Center at Erasmus University, and till April 1st 2014 (retirement date) the Head of the Interventional Department, Thorax Center, Erasmus MC (University Medical Center Rotterdam), Rotterdam, The Netherlands. ...
” The space features a fully equipped “Customer Experience Center” that simulates the robotic setup in a hospital catheterization lab and control room that will include remote capabilities over various types of connections. ...
” The new reimbursement code (designated C9782) is for a blinded procedure for New York Heart Association (NYHA) class ii or iii heart failure, or Canadian Cardiovascular Society (CCS) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells or placebo control, autologous bone marrow harvesting and preparation for ...
“The bioadaptor is a revolutionary innovation in percutaneous coronary intervention and we are enthusiastic about studying the device’s ability to accommodate and restore vessel movement and function,” said Shigeru Saito, MD, Director of the Cardiology and Catheterization Laboratory at Shonan Kamakuru General Hospital, Kanagawa, Japan, and principal investigator ...
Millions of people rely on self-catheterization to empty their bladder due to conditions such as urinary bladder retention, spinal cord injury, traumatic brain injury, multiple sclerosis, and more. ...
More than a million procedures per year are performed in the country, and the number of catheterization labs has doubled since 2010 – now reaching 2,000. This procedure comes only one year after the joint venture setup; it marks a key step in its development. ...
ByRobocath
Recent studies suggest that five to 15 percent of patients undergoing cardiac catheterization have significant disease that cannot be treated with revascularization.3,4 It is estimated that between 600,000 and 1.8 million U.S. patients suffer from refractory angina, with approximately 75,000 new cases diagnosed each year.5 These patients experience poor perceived health status ...
Rosenfield is the Section Head for Vascular Medicine and Intervention and chairs the Acute Myocardial Infarction (STEMI) Committee for the Cardiac Catheterization Laboratory at Massachusetts General Hospital. “We continue to advance our global growth plans in our Asian markets. ...
The initial patients were treated by Dr. Thomas Jones, Cardiac Catheterization Laboratory Director at Seattle Children’s Hospital (Seattle, WA), Dr. ...
The initial patients were treated by Dr. Thomas Jones, Cardiac Catheterization Laboratory Director at Seattle Children’s Hospital (Seattle, WA), Dr. ...
The 5G pilots, which enable clinicians to be transported into operating theatres virtually, were conducted at University Hospital of Wales and University Hospital Llandough. Proximie has teamed up with Vodafone to pilot the role of 5G in increasing the connectivity and performance of remote assistance and training in cancer care. Trial with the assistance of 5G in using Proxime to ...
Shigeru Saito, MD, Director of the Cardiology and Catheterization Laboratory at Shonan Kamakura General Hospital, Kanagawa, Japan is the principal investigator of the BIOADAPTOR RCT. ...
Antonio Colombo, MD, co-principal investigator of the study, Professor of Cardiology at Humanitas Medical School, Senior Consultant in Interventional Cardiology at Humanitas Research Hospital, Rossano, Milan, and Director of the Cardiac Catheterization Laboratory in Columbus Hospital, Milan, Italy, presented the 24-month results from the clinical study demonstrating: Excellent ...
The first patient in the study was treated by Shigeru Saito, MD, Director of the Cardiology and Catheterization Laboratory at Shonan Kamakura General Hospital in Kanagawa, Japan and principal investigator of the study. ...
“With this approval in Japan, we are positioned to significantly expand our ability to help more clinicians optimize coronary artery disease therapy decisions non-invasively while reducing unnecessary invasive catheterizations and saving ...
Chetcuti, M.D., director of the cardiac catheterization laboratory at the University of Michigan Health System, and Tamim M. ...
Chetcuti, M.D., director of the cardiac catheterization laboratory at the University of Michigan Health System, and Steven Yakubov, M.D., system chief, advanced structural heart disease, Riverside Methodist Hospital/OhioHealth. ...